Built to Adapt – Most Flexible IRT Platform
For over 20 years Almac Clinical Technologies group has been leading the Interactive Response Technology industry, bringing together the most innovative technology and our unparalleled expertise to empower biopharmaceutical industry and help bring new therapies to patients.
We provide our IRT services in Japan, China, Korea, Singapore, and other APAC locations.
Resources
Almac Clinical Technologies Asia-Pacific (APAC) Experience
Supporting 100+ Live Studies!
- Support 200+ clinical trials
- Partnership and cooperation with 60+ clients
- 97% repeat business
- Familiar and fully compliant with local regulatory requirements
Almac Clinical Technologies IRT Suite
Our solutions are pre-packaged to make IRT platform configuration easy and to save precious time and costs. From a rapid out-of-the-box build to virtually limitless customisations- we tailor our product and services to every study’s needs and requirements.
Almac IRT: Global Reach – Local Support
Recognizing the growth in the number of clinical studies that are now conducted in Asia, Almac Clinical Technologies has been expanding our physical presence in the region for years.
30+ project management and technical support professionals
- Direct language support: English, Japanese and Chinese
- 9 AM – 6 PM China/Singapore local time
- Other time zones supported by our UK and US teams with interpreters
- Contact via phone, email, and live chat
- Adhere to Almac global SOPs
IXRS®3 IRT System in China
We’ve been successfully expanding our footprint in China for over 10 years, becoming the leading IRT solution on the market
- Direct language support
- Local business hours
- Familiar and fully complied with local regulatory requirements – HGRAC
- Highly involved with local industry events – China IRT Forum, DIA China and ChinaTrials.
Our teams of IRT experts guide you through the process with ease and transparency and take preemptive steps to keep the study inspection-ready and in compliance 24/7 – so you can confidently cross IRT off your list.